Genes of CXCL10, CD44, B2M, XRCC5, and RPL11 might be potentially druggable genes for patients with LA-NPC metastasis by regulating various biological functions, including cell cycle, cell proliferation, drug resistance, and autophagy. This evidence concerns the gene CXCL10 and nasopharyngeal carcinoma.